Ambroise Adeye

Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer ( <i>Mycobacterium ulcerans</i> Disease)

Annick Chauty, Marie-Françoise Ardant, Ambroise Adeye et al. · Antimicrobial Agents and Chemotherapy · 2007 · 207 citations · Full text

Pharmacy, Pharmacotherapy, Surgery +12

Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study

Quentin B. Vincent, Marie-Françoise Ardant, Ambroise Adeye et al. · The Lancet Global Health · 2014 · 127 citations · Full text

Medicine, Infectious Diseases, Microbiology +8

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial

Richard Odame Phillips, J. Robert, Kabiru Mohamed Abass et al. · The Lancet · 2020 · 110 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Oral Treatment for Mycobacterium ulcerans Infection: Results From a Pilot Study in Benin

Annick Chauty, Marie-Françoise Ardant, Laurent Marsollier et al. · Clinical Infectious Diseases · 2010 · 98 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +17

Secondary Buruli Ulcer Skin Lesions Emerging Several Months after Completion of Chemotherapy: Paradoxical Reaction or Evidence for Immune Protection?

Marie‐Thérèse Ruf, Annick Chauty, Ambroise Adeye et al. · PLoS neglected tropical diseases · 2011 · 71 citations · Full text

Medicine, Dermatology, Pathology +17